Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.

por Pancino, G., Osinaga, E., Charpin, C., Mistro, D., Barque, J. P., Roseto, A.
Publicado 1991

VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.

por Charpin, C., Garcia, S., Bergeret, D., Andrac, L., Horschowski, N., Choux, R., Lavaut, M. N.
Publicado 1998

Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.

por Charpin, C., Garcia, S., Bouvier, C., Devictor, B., Andrac, L., Lavaut, M. N., Allasia, C.
Publicado 1997

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.

por Charpin, C., Garcia, S., Bouvier, C., Martini, F., Lavaut, M. N., Allasia, C., Bonnier, P., Andrac, L.
Publicado 1997

Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome

por Charpin, C, Giusiano, S, Charfi, S, Secq, V, Carpentier, S, Andrac, L, Lavaut, M-N, Allasia, C, Bonnier, P, Garcia, S
Publicado 2009

Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)

por Dales, J P, Garcia, S, Carpentier, S, Andrac, L, Ramuz, O, Lavaut, M N, Allasia, C, Bonnier, P, Taranger-Charpin, C
Publicado 2004

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations

por Secq, V, Villeret, J, Fina, F, Carmassi, M, Carcopino, X, Garcia, S, Metellus, I, Boubli, L, Iovanna, J, Charpin, C
Publicado 2014